Comparison of reactivating and therapeutic efficacy of two salts of the oxime HI-6 against tabun, soman and cyclosarin in rats

Basic and Clinical Pharmacology and Toxicology

Volumn 101, Issue 5, 2007, Pages 328-332

  Kassa, Jiri ^a,b   Jun, Daniel ^b   Kuca, Kamil ^b   Bajgar, Jiri ^b  

^a UNIVERSITY OF DEFENCE   (Czech Republic)

^b UNIVERSITY OF DEFENCE   (Czech Republic)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINESTERASE; CYCLOSARIN; OXIME DERIVATIVE; OXIME DICHLORIDE; OXIME DIMETHANESULPHONATE; SOMAN; TABUN; UNCLASSIFIED DRUG;

ACUTE TOXICITY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN REGION; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG SOLUBILITY; DRUG STABILITY; ENZYME INHIBITION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ATROPINE; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; LETHAL DOSE 50; MALE; MUSCARINIC ANTAGONISTS; ORGANOPHOSPHORUS COMPOUNDS; PHOSPHORIC ACID ESTERS; PYRIDINIUM COMPOUNDS; RATS; SOMAN;

RATTUS;

EID: 34848874867     PISSN: 17427835     EISSN: 17427843     Source Type: Journal    
DOI: 10.1111/j.1742-7843.2007.00126.x     Document Type: Article

References (24)

1. Bajgar J. Organophosphates/nerve agent poisoning: mechanism of action, diagnosis, prophylaxis and treatment. Adv Clin Chem 2004 38 : 151 216.
2. Marrs TC. Organophosphate poisoning. Pharmacol Ther 1993 58 : 51 66.
3. Taylor P. Anticholinesterase agents. In : Hardman JG, Limbird LE (eds). The Pharmacological Basis of Therapeutics. McGraw Hill, New York, 1996 161 76.
4. Kassa J. Review of oximes in the antidotal treatment of poisoning by organophosphorus nerve agents. J Toxicol Clin Toxicol 2002 40 : 803 16.
5. Dawson RM. Review of oximes available for treatment of nerve agent poisoning. J Appl Toxicol 1994 14 : 317 31.
6. Rousseaux CG, Dua AK. Pharmacology of HI-6, an H series oxime. Can J Physiol Pharmacol 1989 67 : 1183 9.
7. Thierman H, Seidl S, Eyer P. HI-6 dimethanesulfonate has better dissolution properties than HI-6 dichloride for application in dry/wet antoinjectors. Int J Pharm 1996 137 : 167 76.
8. Lundy PM, Lecavalier P, Hamilton MG et al. The pharmacokinetics and pharmacodynamics of two salts in swine and efficacy in the treatment of GF and soman poisoning. Toxicology 2005 208 : 399 409.
9. Ellman GL, Courtney DK, Andres V Jr., Feartherstone RM. A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 1961 7 : 88 93.
10. Clement JG, Hansen AS, Boulet CA. Efficacy of HLö-7 and pyrimidoxime as antidotes of nerve agent poisoning in mice. Arch Toxicol 1992 66 : 216 9.
11. Tallarida R, Murray R. Manual of Pharmacological Calculation with Computer Programs. Springer-Verlag, New York, 1987 145.
12. Clement JG. Efficacy of various oximes against GF (cyclohexyl methylphosphonofluoridate) poisoning in mice. Arch Toxicol 1992 66 : 143 4.
13. Lundy PM, Hansen AS, Hand BT, Boulet CA. Comparison of several oximes against poisoning by soman, tabun and GF. Toxicology 1992 72 : 99 105.
14. Kassa J, Cabal J. A comparison of the efficacy of acetylcholinesterase reactivators against cyclohexyl methylphosphonofluoridate (GF agent) by in vitro and in vivo methods. Pharmacol Toxicol 1999 84 : 41 5.
15. Hamilton MG, Lundy PM. HI-6 therapy of soman and tabun poisoning in primates and rodents. Arch Toxicol 1989 63 : 144 9.
16. Kassa J, Cabal J. A comparison of the efficacy of a new asymmetric bispyridinium oxime BI-6 with currently available oximes and H oximes against soman by in vitro and in vivo methods. Toxicology 1999 132 : 111 8.
17. Worek F, Widmann R, Knoff O, Szinicz L. Reactivating potency of obidoxime, pralidoxime, HI-6 and Hlö-7 in human erythrocyte acetylcholinesterase inhibited by highly toxic organophosphorus compounds. Arch Toxicol 1998 21 : 237 43.
18. Kuca K, Cabal J, Jun D, Bajgar J, Hrabinova M. Potency of new structurally different oximes to reactivate cyclosarin-inhibited human brain acetylcholinesterase. J Enzyme Inhib Med Chem 2006 21 : 663 6.
19. Kassa J, Kuca K, Bartosova L, Kunesova G. The development of new structural analogues of oximes for the antidotal treatment of poisoning by nerve agents and the comparison of their reactivating and therapeutic efficacy with currently available oximes. Curr Org Chem 2007 11 : 267 83.
20. Van Helden HPM, Busker RW, Melchers BCP, Bruijnzeel PLB. Pharmacological effects of oximes: how relevant are they? Arch Toxicol 1996 70 : 779 86.
21. Kuca K, Jun D, Bajgar J. Currently used cholinesterase reactivators against nerve agent intoxication: comparison of their effectivity in vitro. Drug Chem Toxicol 2007 30 : 31 40.
22. Kassa J, Kuca K, Cabal J, Paar M. A comparison of the efficacy of new asymmetric bispyridinium oximes (K027, K048) with currently available oximes against tabun by in vivo methods. J Toxicol Environ Health 2006 69 : 1875 82.
23. Krummer S, Thiermann H, Worek F, Eyer P. Equipotent cholinesterase reactivation in vitro by the nerve agent antidotes HI 6 dichloride and HI 6 dimethanesulfonate. Arch Toxicol 2002 76 : 589 95.
24. Jokanovic M, Stojiljkovic MP. Current understanding of the application of pyridinium oximes as cholinesterase reactivators in treatment of organophosphate poisoning. Eur J Pharmacol 2006 553 : 10 17.